☰

Xiufeng Pang, Ph.D.

Affiliations: 
2008 Architectural Engineering The University of Nebraska - Lincoln, Lincoln, NE 
Area:
Mechanical Engineering
Google:
"Xiufeng Pang"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Mingsheng Liu grad student 2008 University of Nebraska - Lincoln
 (Prevention of compressor hunting in DX rooftop unit through supply air temperature optimization.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Xiao X, Feng J, Ma J, et al. (2023) Design, Synthesis, and Pharmacological Evaluation of Multisubstituted Pyrido[4,3-]pyrimidine Analogues Bearing Deuterated Methylene Linkers as Potent KRAS Inhibitors. Journal of Medicinal Chemistry
He P, Feng J, Xia X, et al. (2023) Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance. Journal of Medicinal Chemistry
Guo J, Liu Y, Lv J, et al. (2021) BCL6 confers KRAS-mutant non-small-cell lung cancer resistance to BET inhibitors. The Journal of Clinical Investigation. 131
Hu K, Li K, Lv J, et al. (2019) Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. The Journal of Clinical Investigation
Pang X, Yi Z, Zhang J, et al. (2019) Correction: Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway. Cancer Research. 79: 685
Jiang X, Lu W, Shen X, et al. (2018) Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy. Jci Insight. 3
Wu Z, Lu W, Yu W, et al. (2017) Quantitative and Systems Pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches. Pharmacological Research
Li K, Guo Q, Yang J, et al. (2016) FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway. Oncotarget
Pang X, Liu M. (2016) A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS. Chinese Journal of Cancer. 35: 92
Pang X, Liu M. (2016) Defeat Mutant KRAS with Synthetic Lethality. Small Gtpases. 0
See more...